Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Somerset Pharmaceuticals

Executive Summary

Somerset Pharmaceuticals: President Dana Barnett to chairman and CEO and Melvin Sharoky, MD, to president. The post of chairman is newly-created. Somerset is the joint venture of Mylan, where Barnett is exec VP, and Circa, recently acquired by Watson Pharmaceuticals, of which Sharoky is president. The joint venture partners share equally in sales of Somerset's product Eldepryl (selegiline) for treatment of late-stage Parkinson's disease. "More than 75,000 patients" are taking Eldepryl, the company says...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026681

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel